Skip to search
Skip to main content
Back to Search
Start Over
'MOLTO', A MULTICENTER, OPEN LABEL, UNCONTROLLED, PHASE II CLINICAL TRIAL ON VENETOCLAX, ATEZOLIZUMAB, OBINUTUZUMAB (AVO) COMBINATION IN RICHTER TRANSFORMATION: SAFETY INTERIM ANALYSIS
Authors :
Frustaci, A Tedeschi, A Zinzani, P Pietrasanta, D Coscia, M Zenz, T Motta, M Gaidano, G Scarfo, L Deodato, M Zamprogna, G Vitale, C Cairoli, R Rossi, D Montillo, M Frustaci, AM Zinzani, PL Frustaci, A Tedeschi, A Zinzani, P Pietrasanta, D Coscia, M Zenz, T Motta, M Gaidano, G Scarfo, L Deodato, M Zamprogna, G Vitale, C Cairoli, R Rossi, D Montillo, M Frustaci, AM Zinzani, PL
Publication Year :
2021
Details
Database :
OAIster
Notes :
English
Publication Type :
Electronic Resource
Accession number :
edsoai.on1376713685
Document Type :
Electronic Resource